Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines
Current Medical Research and Opinion, 08/20/09
Simoens S – CAP guidelines need to take into account pharmaco–economic considerations by balancing the effectiveness of antimicrobial regimens against their costs. The pharmaco–economic value of moxifloxacin is influenced by the causative pathogens involved and resistance patterns. Therefore, it may be advisable to identify patient subgroups in which treatment with moxifloxacin is cost–effective and should be recommended by guidelines.
Related Articles
Influenza is a Major Contributor to Childhood Pneumonia in a Tropical Developing Country
The Pediatric Infectious Disease Journal, 10/05/09
Relevance Score: 93%
Streptococcus pneumoniae-associated haemolytic uremic syndrome following influenza A virus infection
European Journal of Pediatrics, 11/17/09
Relevance Score: 92%
Discordant Chest Radiographs - A Pitfall in Febrile Elderly Patients With Pneumonia
International Journal of Gerontology, 10/09/09
Relevance Score: 92%
Monomicrobial necrotizing fasciitis in a white male caused by hypermucoviscous Klebsiella pneumoniae
Journal of Medical Microbiology, 10/21/09
Relevance Score: 91%
Role of atypical pathogens among adult hospitalized patients with community-acquired pneumonia
Respirology, 10/09/09
Relevance Score: 90%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases
Current Medical Research and Opinion, 12/18/09
Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
Clinical Interventions in Aging, 12/18/09
Iron supplementation in the non-dialysis chronic kidney disease patient: oral or intravenous
Current Medical Research and Opinion, 12/18/09
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia
Current Medical Research and Opinion, 12/18/09
Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia
Health Policy, 12/16/09
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


